Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiang Tang San Hao Formula is a traditional Chinese medicine prescription, widely used for the management of type 2 diabetes mellitus and related metabolic disorders. It is a multi-ingredient herbal formulation that typically contains Panax ginseng, Atractylodes macrocephala, Coptis chinensis, and Salvia miltiorrhiza, among other herbs[6]. Preclinical studies have shown that JTSHF improves glycemic control, enhances insulin sensitivity, and ameliorates glucose and lipid metabolism in models of type 2 diabetes. Its mechanisms appear to involve the regulation of GLUT4 expression and translocation in skeletal muscle via the AMPKα/SIRT1/PGC-1α signaling pathway[1][2], as well as modulation of the gut-microbiota-brain axis, influencing gut microbiota composition, short-chain fatty acids, and hypothalamic neuropeptide expression to regulate feeding and metabolic homeostasis[4]. JTSHF also increases serum GLP-1 and decreases ghrelin, contributing to improved glucose control[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jiang Tang San Hao Formula.